drugset / Trial / NCT01925313
A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study objectives * To compare the safety and pharmacokinetic properties of CJ-30044 and bepotastine besylate after a single oral administration in healthy male volunteers. * To evaluate the food-effect on pharmacokinetics of CJ-30044 after a single oral administration in healthy male volunteers.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-02
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bepotastine | Small molecule | 10 mg | Oral |
| Subject | CJ-30044 | Unknown | 20.51 mg | Oral |
Indications
No indication recorded.